论文部分内容阅读
不久前,浙江某晚报在头版头条,以《冯根生,该不该持300万元股?》为题报道:国内中药行业经济效益最好的企业——正大青春宝药业有限公司董事会全票作出一项决定,从公司现有的净资产中划出15％作为个人股票卖给员工及经营者,通过“工者有其股”,把员工、经营者和企业的长远利益紧密地捆在一起,更快更好地发展壮大“青春宝”。按董事会的决议,在这次内部股份制改造中,冯根生作为主要经营者,至少要认购2％的股
Not long ago, Zhejiang Evening News reported on the front page of the headline that “Feng Gensheng should not hold 3 million yuan shares?” as the subject: The most cost-effective enterprise in the domestic Chinese medicine industry – the board of directors of Zhengda Youth Po Pharmaceutical Co., Ltd. made all votes. A decision to allocate 15% of the company’s existing net assets to individual employees and managers as individual stocks, and to bind the long-term interests of employees, managers, and companies together by “workers have their shares”. , Faster and better development and growth of “youth treasure.” According to the resolution of the board of directors, Feng Gensheng, as the main operator, has to subscribe for at least 2% of the shares in this internal shareholding reform.